Hilde Windels

Executive Chairman at MyCartis NV

Hilde Windels

Hilde Windels

Executive Chairman at MyCartis NV

Overview
Career Highlights

Biocartis SA
deVGen NV
SEPS Pharma NV

RelSci Relationships

288

Number of Boards

8

Birthday

1965

Age

54

Relationships
RelSci Relationships are individuals Hilde Windels likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer at Camel-IDS NV

Relationship likelihood: Strong

Chief Executive Officer & Director at ERYTECH Pharma SA

Relationship likelihood: Strong

Former Chief Executive Officer at Biocartis Group NV

Relationship likelihood: Strong

Co-Founder Managing Director at LSP Management Group BV

Relationship likelihood: Strong

Managing Director at Viziphar Biosciences BVBA

Relationship likelihood: Strong

Chief Executive Officer at Novigenix SA

Relationship likelihood: Strong

Chief Executive Officer at LMA BVBA

Relationship likelihood: Strong

Chief Executive Officer & Executive Director at Biocartis Group NV

Relationship likelihood: Strong

Chairman at The Insurance Group

Relationship likelihood: Strong

Partner, Health & Care at Gimv NV

Relationship likelihood: Strong

In The News
Paths to Hilde Windels
Potential Connections via
Relationship Science
You
Hilde Windels
Executive Chairman at MyCartis NV
Education
Career History
Chief Financial Officer
2011 - Current

Biocartis SA develops molecular diagnostic solutions. It focuses on Oncology. The firm's products include Idylla and Oncology assays and mutation tests. It also provides instant access to personalized medicine for patients. The company was founded by Rudi Pauwels in 2007 and is headquartered in Lausanne, Switzerland.

Executive Chairman
Current

MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers its products for various disease areas, including cell signaling, cardiovascular, oncology, and preeclampsia. MyCartis was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium.

Executive Chairman
Current

MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers its products for various disease areas, including cell signaling, cardiovascular, oncology, and preeclampsia. MyCartis was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium.

Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Hilde Windels. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Hilde Windels's profile does not indicate a business or promotional relationship of any kind between RelSci and Hilde Windels.